Shares of GE HealthCare Technologies reversed course to trade up 4.4 per cent on their market debut on Wednesday after the medical equipment maker completed its separation from industrial conglomerate General Electric.
GE said in 2021 it would split into three public companies to simplify its business, pare down debt and breathe life into battered shares.
However, the conglomerate’s stock fell 11.3 per cent last year as it struggled with parts and labour shortages. The group’s shares were up 2 per cent on Wednesday.
But the healthcare unit, in which GE will hold a 19.9 per cent stake after the spin-off, has been a bright spot in recent quarters, as strong demand for its medical equipment and services allowed it to raise prices.
Romantasy, QuitTok and other words from a dystopia-coded year
Have Ireland’s data centre builders shot themselves in the foot through their own greed?
The old order of globalisation may be collapsing – and bringing Germany with it
Wonderwallets: the cost of everything in 2024, from Oasis tickets to Leinster House bike shelter
GE HealthCare – which will operate imaging and ultrasound devices, patient care solutions and pharmaceutical diagnostics businesses – expects its addressable markets will expand to $102 billion (€96.2 billion) by 2025 from $84 billion in 2021.
The company said in December it expects an aging population, chronic diseases and a rise in the middle class in many emerging markets to drive growth targets.
The company will be present in more than 160 countries and have about 51,000 employees worldwide, GE HealthCare said on Wednesday.
Shares of the company, which is scheduled to release its fourth-quarter and full-year results on January 30th, were trading at $58.40 on the Nasdaq.
– Reuters
